Caplin Point Laboratories Dirección
Dirección controles de criterios 4/4
El CEO de Caplin Point Laboratories es Sridhar Ganesan , nombrado en Mar 2015, tiene una permanencia de 9.67 años. compensación anual total es ₹9.30M, compuesta por 95.7% salario y 4.3% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.13% de las acciones de la empresa, por valor de ₹195.26M. La antigüedad media del equipo directivo y de la junta directiva es de 8.8 años y 3.4 años, respectivamente.
Información clave
Sridhar Ganesan
Chief Executive Officer (CEO)
₹9.3m
Compensación total
| Porcentaje del salario del CEO | 95.7% |
| Permanencia del CEO | 9.7yrs |
| Participación del CEO | 0.1% |
| Permanencia media de la dirección | 8.8yrs |
| Promedio de permanencia en la Junta Directiva | 3.4yrs |
Actualizaciones recientes de la dirección
Recent updates
₹2,142 - That's What Analysts Think Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Is Worth After These Results
Nov 10
With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case
Oct 31Caplin Point Laboratories (NSE:CAPLIPOINT) Is Due To Pay A Dividend Of ₹2.50
Sep 12Earnings Update: Here's Why Analysts Just Lifted Their Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Price Target To ₹1,764
Aug 11Caplin Point Laboratories (NSE:CAPLIPOINT) Is Paying Out A Dividend Of ₹2.50
Aug 10Investors Aren't Buying Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Earnings
Jul 12Caplin Point Laboratories (NSE:CAPLIPOINT) Strong Profits May Be Masking Some Underlying Issues
May 24Does Caplin Point Laboratories (NSE:CAPLIPOINT) Deserve A Spot On Your Watchlist?
May 04Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Low P/E No Reason For Excitement
Mar 07With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case
Oct 24Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise
Sep 15Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹2.50
Aug 11We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise
Sep 23Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 11Is Now The Time To Put Caplin Point Laboratories (NSE:CAPLIPOINT) On Your Watchlist?
Jul 22Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹2.00
May 15A Look At The Intrinsic Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
Jan 21Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?
Oct 20Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹1.50
Sep 17Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹1.50
Sep 03Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Intrinsic Value Is Potentially 28% Above Its Share Price
Aug 27Is Caplin Point Laboratories (NSE:CAPLIPOINT) A Risky Investment?
Jun 12Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹5b |
| Jun 30 2024 | n/a | n/a | ₹5b |
| Mar 31 2024 | ₹9m | ₹9m | ₹5b |
| Dec 31 2023 | n/a | n/a | ₹4b |
| Sep 30 2023 | n/a | n/a | ₹4b |
| Jun 30 2023 | n/a | n/a | ₹4b |
| Mar 31 2023 | ₹9m | ₹8m | ₹4b |
| Dec 31 2022 | n/a | n/a | ₹4b |
| Sep 30 2022 | n/a | n/a | ₹3b |
| Jun 30 2022 | n/a | n/a | ₹3b |
| Mar 31 2022 | ₹6m | ₹5m | ₹3b |
| Dec 31 2021 | n/a | n/a | ₹3b |
| Sep 30 2021 | n/a | n/a | ₹3b |
| Jun 30 2021 | n/a | n/a | ₹3b |
| Mar 31 2021 | ₹6m | ₹5m | ₹2b |
| Dec 31 2020 | n/a | n/a | ₹2b |
| Sep 30 2020 | n/a | n/a | ₹2b |
| Jun 30 2020 | n/a | n/a | ₹2b |
| Mar 31 2020 | ₹6m | ₹6m | ₹2b |
| Dec 31 2019 | n/a | n/a | ₹2b |
| Sep 30 2019 | n/a | n/a | ₹2b |
| Jun 30 2019 | n/a | n/a | ₹2b |
| Mar 31 2019 | ₹6m | ₹6m | ₹2b |
| Dec 31 2018 | n/a | n/a | ₹2b |
| Sep 30 2018 | n/a | n/a | ₹2b |
| Jun 30 2018 | n/a | n/a | ₹1b |
| Mar 31 2018 | ₹6m | ₹6m | ₹1b |
Compensación vs. Mercado: La compensación total de Sridhar($USD110.35K) está por debajo de la media de empresas de tamaño similar en el mercado Indian ($USD481.61K).
Compensación vs. Ingresos: La compensación de Sridhar ha sido consistente con los resultados de la empresa en el último año.
CEO
Sridhar Ganesan (69 yo)
9.7yrs
Permanencia
₹9,300,000
Compensación
Dr. Sridhar Ganesan has been the Managing Director of Caplin Point Laboratories Ltd since March 28, 2015. Dr. Ganesan has been Whole Time Director of Caplin Point Laboratories Ltd since August 25, 2014. He...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| MD & Whole Time Director | 9.7yrs | ₹9.30m | 0.13% ₹ 195.3m | |
| Chief Financial Officer | 8.8yrs | ₹9.10m | 0.020% ₹ 30.0m | |
| Chief Operating Officer | 13.3yrs | ₹1.90m | 11.84% ₹ 17.8b | |
| General Counsel | 2.3yrs | ₹6.50m | sin datos | |
| Deputy Chief Financial Officer | no data | sin datos | sin datos | |
| Head of Marketing - Latam Business | no data | sin datos | 11.91% ₹ 17.9b | |
| Chief Transformation & Digital Officer | less than a year | sin datos | sin datos |
8.8yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de CAPLIPOINT es experimentado (8.8 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| MD & Whole Time Director | 10.8yrs | ₹9.30m | 0.13% ₹ 195.3m | |
| Non-Executive Non-Independent Chairman | 34.6yrs | sin datos | 18.64% ₹ 28.0b | |
| Non-Executive Independent Director | 4.7yrs | ₹140.00k | sin datos | |
| Non-Executive Independent Director | 2.2yrs | ₹160.00k | sin datos | |
| Independent Non-Executive Director | 2.2yrs | ₹180.00k | 0.000090% ₹ 135.3k | |
| Independent Director | less than a year | sin datos | sin datos |
3.4yrs
Permanencia media
72yo
Promedio de edad
Junta con experiencia: La junta directiva de CAPLIPOINT se considera experimentada (3.4 años de antigüedad promedio).